Healthcare Triangle, Inc. (HCTI) AI Stock Analysis

Healthcare Triangle, Inc. is a healthcare information technology company that delivers cloud services, data science, and professional and managed services to healthcare delivery organizations, insurance providers, pharmaceutical and life sciences firms, biotech enterprises, and medical device manufacturers. Its primary proprietary software platforms include CloudEz for multi-cloud infrastructure management, DataEz for cloud-based data science and analytics, and Readabl.AI for extracting data from narrative documents using artificial intelligence. The company also offers cloud IT services, electronic health records implementation and optimization, application managed services, and public cloud disaster recovery solutions.

Revenue registered a 5-year CAGR of -15.0% between FY2020 and FY2025. Annual revenue reached $45.9M in FY2022 before dropping to $33.2M in FY2023 and $11.7M in FY2024. In FY2025, revenue increased 18.8% to $13.9M, but gross margin compressed to 13.6% from 24.7% in FY2024, while operating margin was -70.5% with net income of -$9.5M. For the trailing twelve months ended June 30, 2026, revenue stood at $25.7M with an operating margin of -44.3% and a net margin of -66.3%. For the latest quarter ended June 30, 2026, quarterly revenue grew 158.4% year-over-year.

As of June 30, 2026, Healthcare Triangle held $1.9M in cash and short-term investments against $13.0M in total debt, resulting in net debt of $11.1M. The company reported a current ratio of 0.60, total assets of $73.6M, and shareholders' equity of $49.1M, with a debt-to-equity ratio of 0.26. Operating cash flow in FY2025 was -$16.5M, matching a free cash flow of -$16.5M after capital expenditures of $6,000. Over the past five years, the company's share count increased by 1402650.0%.

Healthcare Triangle trades at an enterprise value of $49.9M and a market capitalization of $6.0M. Its price-to-sales multiple is 0.2x, below the 4.1x median of its US-listed Healthcare peers, while its enterprise value-to-revenue multiple is 1.9x and price-to-book is 0.6x. The peer group median operating margin is 14.0%, compared to the company's -44.3% trailing operating margin. Over the past year, HCTI shares returned -99.7% while the S&P 500 benchmark SPY returned 16.8%, and over five years the stock returned -100.0% compared to 83.0% for SPY.

Healthcare Triangle has coverage from 1 analyst for the next fiscal year. The mean price target is $3.15, which is 691.5% above the last close of $0.40 on October 16, 2026. For the current fiscal year ending December 31, 2026, consensus estimates project revenue of $38.8M and EPS of -$10.23, representing 93.3% estimated EPS growth. For the next fiscal year, analysts forecast revenue of $40.5M and EPS of -$3.18. The company has beaten EPS estimates in 1 of the last 4 quarters, and its next earnings date is November 12, 2026.

This page is an AI-written research summary of Healthcare Triangle, Inc. (HCTI). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: HCTI income statement, HCTI balance sheet, HCTI key metrics, HCTI analyst forecast, HCTI chart. See the HCTI stock overview for the latest quote and news.